Accessibility Menu
 

Zura Bio

(NASDAQ) ZURA

Current Price$5.42
Market Cap$480.26M
Since IPO (2021)-43%
5 YearN/A
1 Year+299%
1 Month-13%

Zura Bio Financials at a Glance

Market Cap

$480.26M

Revenue (TTM)

$0.00

Net Income (TTM)

$99.35M

EPS (TTM)

$-1.19

P/E Ratio

-4.67

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$5.42

Volume

547,421.838

Open

$5.48

Previous Close

$5.38

Daily Range

$5.31 - $5.88

52-Week Range

$0.97 - $7.44

ZURA News

ZURA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zura Bio

Industry

Biotechnology

Employees

40

CEO

Kimberly Ann Davis

Headquarters

San Diego, CA 92037, US

ZURA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-80%

Return on Capital

-74%

Return on Assets

-87%

Earnings Yield

-21.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$480.26M

Shares Outstanding

86.22M

Volume

547.42K

Short Interest

0.00%

Avg. Volume

684.15K

Financials (TTM)

Gross Profit

$49.00K

Operating Income

$75.25M

EBITDA

$75.25M

Operating Cash Flow

$64.81M

Capital Expenditure

$113.00K

Free Cash Flow

$64.93M

Cash & ST Invst.

$109.41M

Total Debt

$0.00

Zura Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$15.00K

-200.0%

Gross Margin

0.00%

N/A

Market Cap

$480.26M

N/A

Market Cap/Employee

$16.01M

N/A

Employees

30

N/A

Net Income

$45.88M

-407.1%

EBITDA

$18.41M

-35.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$109.41M

-38.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-87.19%

N/A

Return on Invested Capital

-74.11%

N/A

Free Cash Flow

$22.30M

-105.1%

Operating Cash Flow

$22.28M

-105.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NAUTNautilus Biotechnology, Inc.
$3.95+9.12%
ASMBAssembly Biosciences, Inc.
$28.23-1.22%
FHTXFoghorn Therapeutics Inc.
$4.80-5.70%
ENTAEnanta Pharmaceuticals, Inc.
$12.08-4.51%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$175.20-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%

Questions About ZURA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.